{"symbol": "BVXV", "name": "BiondVax Pharmaceuticals", "next_earnings_utc": 1592478000, "next_earnings_period_start_date_utc": 1585612800, "next_earnings_period_end_date_utc": null, "next_earnings_has_time": true, "next_earnings_name": "None QNone", "next_earnings_year": null, "next_earnings_quarter": null, "next_earnings_revenue_num_analysts": null, "next_earnings_revenue_consensus": null, "next_earnings_eps_num_analysts": null, "next_earnings_eps_consensus": null, "eps_up_revisions": 0, "eps_down_revisions": 0, "revenue_up_revisions": 0, "revenue_down_revisions": 0, "total_analysts": 0, "analysts_sell": 0, "analysts_buy": 0, "analysts_outperform": 0, "analysts_hold": 0, "analysts_underperform": 0, "webpage": "biondvax.com", "year_founded": 2003, "street_address": "Jerusalem BioPark", "city": "Jerusalem", "state": null, "zipcode": "7414002", "country": "Israel", "phone_number": "972 8 930 2529", "short_description": "BiondVax Pharmaceuticals Ltd., a clinical stage biopharmaceutical company, focuses on developing and commercializing immunomodulation therapies for infectious diseases primarily in Israel.", "long_description": "BiondVax Pharmaceuticals Ltd., a clinical stage biopharmaceutical company, focuses on developing and commercializing immunomodulation therapies for infectious diseases primarily in Israel. Its product candidate is M-001, a synthetic peptide-based protein, which is in Phase III clinical trials that is used for treating seasonal and pandemic strains of the influenza virus. The company was founded in 2003 and is headquartered in Jerusalem, Israel.", "industry_name": "Pharmaceuticals", "sector_name": "Health Care", "is_defunct": false, "exchange": "NASDAQ", "equity_type": "stocks", "market_cap": 204609526, "total_enterprise": 216308577, "number_of_employees": 21, "outstanding_shares": 10359976, "eps": -4.54514901329037, "diluted_eps": -4.54514901329037, "earnings_from_cont_operations": -32208158, "gross_profit": null, "cash": 21646338, "total_debt": 33354813, "total_revenue": null, "cash_from_operations": -19078592, "net_income": -32208158, "ebitda": -20896381, "year_low_stock_price": 5.2, "year_high_stock_price": 25.5, "seekingalpha_follower_count": 1059, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/BVXV.png"}